GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FSD Pharma Inc (NAS:HUGE) » Definitions » FCF Yield %

FSD Pharma (FSD Pharma) FCF Yield % : -74.60 (As of May. 16, 2024)


View and export this data going back to 2018. Start your Free Trial

What is FSD Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, FSD Pharma's Trailing 12-Month Free Cash Flow is $-10.83 Mil, and Market Cap is $13.32 Mil. Therefore, FSD Pharma's FCF Yield % for today is -74.60%.

The historical rank and industry rank for FSD Pharma's FCF Yield % or its related term are showing as below:

HUGE' s FCF Yield % Range Over the Past 10 Years
Min: -499.9   Med: -110.96   Max: -0.32
Current: -74.6


During the past 9 years, the highest FCF Yield % of FSD Pharma was -0.32%. The lowest was -499.90%. And the median was -110.96%.

HUGE's FCF Yield % is ranked worse than
93.16% of 1082 companies
in the Drug Manufacturers industry
Industry Median: -0.52 vs HUGE: -74.60

FSD Pharma's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.


FSD Pharma FCF Yield % Historical Data

The historical data trend for FSD Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FSD Pharma FCF Yield % Chart

FSD Pharma Annual Data
Trend Aug15 Aug16 Aug17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only -32.63 -64.00 -51.49 -94.53 -29.89

FSD Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -83.32 -31.43 -31.26 -14.38 -9.41

Competitive Comparison of FSD Pharma's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, FSD Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FSD Pharma's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, FSD Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where FSD Pharma's FCF Yield % falls into.



FSD Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

FSD Pharma's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-10.827 / 36.21878064
=-29.89%

FSD Pharma's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.852 * 4 / 36.21878064
=-9.41%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FSD Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


FSD Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of FSD Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


FSD Pharma (FSD Pharma) Business Description

Traded in Other Exchanges
Address
199 Bay Street, Suite 4000, Toronto, ON, CAN, M5L 1A9
FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The Company operates in two segments: Biotechnology and Strategic Investments.

FSD Pharma (FSD Pharma) Headlines

From GuruFocus